| abstract |
The present invention relates to products and compositions and their uses. In particular, the present invention relates to nucleic acid products that interfere with or inhibit the expression of the LPA gene for use in the treatment, prevention of cardiovascular diseases such as coronary heart disease or aortic stenosis or stroke or in combination with Lp(a)-containing particles Any other condition, pathology or syndrome associated with high, or reduced suffering from cardiovascular disease such as coronary heart disease or aortic stenosis or stroke or any other condition, pathology or syndrome associated with elevation of Lp(a) containing particles risk of symptoms. |